
Terrascend increases New Jersey dispensaries to four
Terrascend increases New Jersey dispensaries to four

Terrascend increases New Jersey dispensaries to four
Pharmacielo cease trade order revoked by OSC
Vencanna Ventures Announces Interim Financial Results and Corporate Update for the Three and Six Months ending October 31, 2025
TerrAscend Increases Retail Footprint in New Jersey with Closing of Union Chill Dispensary Transaction
Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
PharmaCielo Announces Revocation of FFCTO and Related Corporate Matters
1933 Industries Provides Update on 2024 Debenture Conversions
Mercanto Holdings loses $146,213 in fiscal Q1 2026
Leef Brands receives $237,000 from debenture conversion
LEEF Brands Announces Full Early Conversion of CAD Convertible Debentures
Mercanto Holdings Inc. Reports Q1 Fiscal 2026 Financial Results
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
Hempalta closes financing tranche, appoints new auditor
Hempalta Announces Closing of First Tranche of Private Placement, Debt Settlements, Change of Auditor, Board of Directors Changes and Grant of Stock Options
High Tide looks back at milestones from 2025